UK DoH builds team ahead of new tissue body:
This article was originally published in Clinica
The UK's Department of Health has appointed one new member to the UK's Human Fertilisation and Embryology Authority, and re-appointed three current members, in what it sees as an important step towards the creation of the Regulatory Authority for Fertility and Tissue (RAFT). Mr Hossam Abdalla, a consultant obstetrician and gynaecologist and director of the assisted conception unit at London's Lister Hospital, will serve for three years. Professor Christopher Barratt will remain for a similar term, while Sara Nathan and Sharmila Nebhrajani will serve for one more year. RAFT is set to replace the HFEA and the Human Tissue Authority by 2008 (see Clinica No 1134, p 5).
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.